1-s2.0-S1684118217300075.pdf (2.52 MB)
Download file

Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa

Download (2.52 MB)
journal contribution
posted on 11.07.2019, 11:21 by R Hassan, W El-Naggar, AM Abd El-Aziz, M Shaaban, HI Kenawy, YM Ali
Background Pseudomonas aeruginosa is a Gram-negative opportunistic bacterium, which considered as a common cause of nosocomial infection and life-threatening complications in immunocompromized and cystic fibrosis patients. Here, we evaluate the protective effect of recombinant vaccines composed of outer membrane proteins OprF and OprI alone or in combination with flagellin B against mucoid and nonmucoid pseudomonas infection. Methods BALB/C mice were immunized subcutaneous using OprF and OprI with or without flagellin B and antibody titers were determined. Serum bactericidal and opsonophagocytosis activities of immunized and control sera were estimated against mucoid and nonmucoid pseudomonas strains. Lung tissue sections from immunized and nonimmunized mice were analyzed and the levels of peripheral neutrophils infiltration into the lung and tissue inflammation were scored. Results Subcutaneous immunization using OprF and OprI with or without flagellin B elicited higher antibody titers against OprF, OprI, and flagellin B. The produced antibodies successfully opsonized both mucoid and nonmucoid strains with subsequent activation of the terminal pathway of complement that enhances killing of nonmucoid strains via complement-mediated lysis. Furthermore, opsonized mucoid and nonmucoid strains showed enhanced opsonophagocytosis via human peripheral neutrophils, a mechanism that kills P. aeruginosa when complement mediated lysis is not effective especially with mucoid strains. Immunized mice also showed a significant prolonged survival time, lower bacteremia, and reduced lung damage when compared with control nonimmunized mice. Conclusion Our data showed that mice immunized with OprF/OprI or OprF/OprI and flagellin B are significantly protected from infection caused by mucoid and nonmucoid strains of P. aeruginosa .

History

Citation

Journal of Microbiology, Immunology and Infection, 2018, 51 (3), pp. 312-320

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Infection, Immunity and Inflammation

Version

VoR (Version of Record)

Published in

Journal of Microbiology

Publisher

Elsevier for Chinese Society of Immunology, Infectious Diseases Society of Taiwan, Taiwan Society of Microbiology, Taiwan Society of Parasitology [C

issn

1684-1182

Acceptance date

08/08/2016

Copyright date

2017

Available date

11/07/2019

Publisher version

https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1684118217300075?returnurl=https://linkinghub.elsevier.com/retrieve/pii/S1684118217300075?showall=true&referrer=

Notes

Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.jmii.2016.08.014.

Language

en